Allele-Specific Expression at the RET Locus in Blood and Gut Tissue of Individuals Carrying Risk Alleles for Hirschsprung Disease

Ivana Matera, Marco Musso, Paola Griseri, Marta Rusmini, Marco Di Duca, Man Ting So, Domenico Mavilio, Xiaoping Miao, Paul Hk Tam, Roberto Ravazzolo, Isabella Ceccherini, Merce Garcia-Barcelo

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

RET common variants are associated with Hirschsprung disease (HSCR; colon aganglionosis), a congenital defect of the enteric nervous system. We analyzed a well-known HSCR-associated RET haplotype that encompasses linked alleles in coding and noncoding/regulatory sequences. This risk haplotype correlates with reduced level of RET expression when compared with the wild-type counterpart. As allele-specific expression (ASE) contributes to phenotypic variability in health and disease, we investigated whether RET ASE could contribute to the overall reduction of RET mRNA detected in carriers. We tested heterozygous neuroblastoma cell lines, ganglionic gut tissues (18 HSCR and 14 non-HSCR individuals) and peripheral blood mononuclear cells (PBMCs; 16 HSCR and 14 non-HSCR individuals). Analysis of the data generated by SNaPshot and Pyrosequencing revealed that the RET risk haplotype is significantly more expressed in gut than in PBMCs (P = 0.0045). No ASE difference was detected between patients and controls, irrespective of the sample type. Comparison of total RET expression levels between gut samples with and without ASE, correlated reduced RET expression with preferential transcription from the RET risk haplotype. Nonrandom RET ASE occurs in ganglionic gut regardless of the disease status. RET ASE should not be excluded as a disease mechanism acting during development.

Original languageEnglish
Pages (from-to)754-762
Number of pages9
JournalHuman Mutation
Volume34
Issue number5
DOIs
Publication statusPublished - May 2013

Fingerprint

Hirschsprung Disease
Alleles
Haplotypes
Enteric Nervous System
Neuroblastoma
Blood Cells
Colon
Cell Line
Messenger RNA
Health

Keywords

  • Allele-specific expression
  • Hirschprung disease
  • Regulatory polymorphisms
  • RET

ASJC Scopus subject areas

  • Genetics
  • Genetics(clinical)

Cite this

Matera, I., Musso, M., Griseri, P., Rusmini, M., Di Duca, M., So, M. T., ... Garcia-Barcelo, M. (2013). Allele-Specific Expression at the RET Locus in Blood and Gut Tissue of Individuals Carrying Risk Alleles for Hirschsprung Disease. Human Mutation, 34(5), 754-762. https://doi.org/10.1002/humu.22302

Allele-Specific Expression at the RET Locus in Blood and Gut Tissue of Individuals Carrying Risk Alleles for Hirschsprung Disease. / Matera, Ivana; Musso, Marco; Griseri, Paola; Rusmini, Marta; Di Duca, Marco; So, Man Ting; Mavilio, Domenico; Miao, Xiaoping; Tam, Paul Hk; Ravazzolo, Roberto; Ceccherini, Isabella; Garcia-Barcelo, Merce.

In: Human Mutation, Vol. 34, No. 5, 05.2013, p. 754-762.

Research output: Contribution to journalArticle

Matera, Ivana ; Musso, Marco ; Griseri, Paola ; Rusmini, Marta ; Di Duca, Marco ; So, Man Ting ; Mavilio, Domenico ; Miao, Xiaoping ; Tam, Paul Hk ; Ravazzolo, Roberto ; Ceccherini, Isabella ; Garcia-Barcelo, Merce. / Allele-Specific Expression at the RET Locus in Blood and Gut Tissue of Individuals Carrying Risk Alleles for Hirschsprung Disease. In: Human Mutation. 2013 ; Vol. 34, No. 5. pp. 754-762.
@article{51605300098d4ec5bb21c1e3f9c9a7ef,
title = "Allele-Specific Expression at the RET Locus in Blood and Gut Tissue of Individuals Carrying Risk Alleles for Hirschsprung Disease",
abstract = "RET common variants are associated with Hirschsprung disease (HSCR; colon aganglionosis), a congenital defect of the enteric nervous system. We analyzed a well-known HSCR-associated RET haplotype that encompasses linked alleles in coding and noncoding/regulatory sequences. This risk haplotype correlates with reduced level of RET expression when compared with the wild-type counterpart. As allele-specific expression (ASE) contributes to phenotypic variability in health and disease, we investigated whether RET ASE could contribute to the overall reduction of RET mRNA detected in carriers. We tested heterozygous neuroblastoma cell lines, ganglionic gut tissues (18 HSCR and 14 non-HSCR individuals) and peripheral blood mononuclear cells (PBMCs; 16 HSCR and 14 non-HSCR individuals). Analysis of the data generated by SNaPshot and Pyrosequencing revealed that the RET risk haplotype is significantly more expressed in gut than in PBMCs (P = 0.0045). No ASE difference was detected between patients and controls, irrespective of the sample type. Comparison of total RET expression levels between gut samples with and without ASE, correlated reduced RET expression with preferential transcription from the RET risk haplotype. Nonrandom RET ASE occurs in ganglionic gut regardless of the disease status. RET ASE should not be excluded as a disease mechanism acting during development.",
keywords = "Allele-specific expression, Hirschprung disease, Regulatory polymorphisms, RET",
author = "Ivana Matera and Marco Musso and Paola Griseri and Marta Rusmini and {Di Duca}, Marco and So, {Man Ting} and Domenico Mavilio and Xiaoping Miao and Tam, {Paul Hk} and Roberto Ravazzolo and Isabella Ceccherini and Merce Garcia-Barcelo",
year = "2013",
month = "5",
doi = "10.1002/humu.22302",
language = "English",
volume = "34",
pages = "754--762",
journal = "Human Mutation",
issn = "1059-7794",
publisher = "John Wiley and Sons Inc.",
number = "5",

}

TY - JOUR

T1 - Allele-Specific Expression at the RET Locus in Blood and Gut Tissue of Individuals Carrying Risk Alleles for Hirschsprung Disease

AU - Matera, Ivana

AU - Musso, Marco

AU - Griseri, Paola

AU - Rusmini, Marta

AU - Di Duca, Marco

AU - So, Man Ting

AU - Mavilio, Domenico

AU - Miao, Xiaoping

AU - Tam, Paul Hk

AU - Ravazzolo, Roberto

AU - Ceccherini, Isabella

AU - Garcia-Barcelo, Merce

PY - 2013/5

Y1 - 2013/5

N2 - RET common variants are associated with Hirschsprung disease (HSCR; colon aganglionosis), a congenital defect of the enteric nervous system. We analyzed a well-known HSCR-associated RET haplotype that encompasses linked alleles in coding and noncoding/regulatory sequences. This risk haplotype correlates with reduced level of RET expression when compared with the wild-type counterpart. As allele-specific expression (ASE) contributes to phenotypic variability in health and disease, we investigated whether RET ASE could contribute to the overall reduction of RET mRNA detected in carriers. We tested heterozygous neuroblastoma cell lines, ganglionic gut tissues (18 HSCR and 14 non-HSCR individuals) and peripheral blood mononuclear cells (PBMCs; 16 HSCR and 14 non-HSCR individuals). Analysis of the data generated by SNaPshot and Pyrosequencing revealed that the RET risk haplotype is significantly more expressed in gut than in PBMCs (P = 0.0045). No ASE difference was detected between patients and controls, irrespective of the sample type. Comparison of total RET expression levels between gut samples with and without ASE, correlated reduced RET expression with preferential transcription from the RET risk haplotype. Nonrandom RET ASE occurs in ganglionic gut regardless of the disease status. RET ASE should not be excluded as a disease mechanism acting during development.

AB - RET common variants are associated with Hirschsprung disease (HSCR; colon aganglionosis), a congenital defect of the enteric nervous system. We analyzed a well-known HSCR-associated RET haplotype that encompasses linked alleles in coding and noncoding/regulatory sequences. This risk haplotype correlates with reduced level of RET expression when compared with the wild-type counterpart. As allele-specific expression (ASE) contributes to phenotypic variability in health and disease, we investigated whether RET ASE could contribute to the overall reduction of RET mRNA detected in carriers. We tested heterozygous neuroblastoma cell lines, ganglionic gut tissues (18 HSCR and 14 non-HSCR individuals) and peripheral blood mononuclear cells (PBMCs; 16 HSCR and 14 non-HSCR individuals). Analysis of the data generated by SNaPshot and Pyrosequencing revealed that the RET risk haplotype is significantly more expressed in gut than in PBMCs (P = 0.0045). No ASE difference was detected between patients and controls, irrespective of the sample type. Comparison of total RET expression levels between gut samples with and without ASE, correlated reduced RET expression with preferential transcription from the RET risk haplotype. Nonrandom RET ASE occurs in ganglionic gut regardless of the disease status. RET ASE should not be excluded as a disease mechanism acting during development.

KW - Allele-specific expression

KW - Hirschprung disease

KW - Regulatory polymorphisms

KW - RET

UR - http://www.scopus.com/inward/record.url?scp=84876315303&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84876315303&partnerID=8YFLogxK

U2 - 10.1002/humu.22302

DO - 10.1002/humu.22302

M3 - Article

C2 - 23441071

AN - SCOPUS:84876315303

VL - 34

SP - 754

EP - 762

JO - Human Mutation

JF - Human Mutation

SN - 1059-7794

IS - 5

ER -